PNC Financial Services Group’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.5K Sell
1,427
-595
-29% -$2.82K ﹤0.01% 4246
2026
Q2
$8.96K Sell
2,022
-15,905
-89% -$67.9K ﹤0.01% 4141
2026
Q1
$78.3K Buy
17,927
+1,590
+10% +$7.51K ﹤0.01% 2969
2025
Q4
$82.5K Sell
16,337
-987
-6% -$4.58K ﹤0.01% 2926
2025
Q3
$60.1K Buy
17,324
+846
+5% +$3.18K ﹤0.01% 3100
2025
Q2
$56K Buy
16,478
+12,662
+332% +$42.2K ﹤0.01% 3047
2025
Q1
$15.3K Sell
3,816
-5,034
-57% -$26.1K ﹤0.01% 3660
2024
Q4
$57.4K Buy
8,850
+4,665
+111% +$27.8K ﹤0.01% 3023
2024
Q3
$23.2K Sell
4,185
-2,587
-38% -$14.7K ﹤0.01% 3441
2024
Q2
$37.8K Buy
6,772
+3,024
+81% +$18.2K ﹤0.01% 3164
2024
Q1
$25.2K Sell
3,748
-2,347
-39% -$18.6K ﹤0.01% 3331
2023
Q4
$55.6K Sell
6,095
-2,267
-27% -$14.3K ﹤0.01% 2917
2023
Q3
$46.2K Buy
8,362
+1,150
+16% +$9.22K ﹤0.01% 3002
2023
Q2
$61.6K Buy
7,212
+6,777
+1,558% +$60.8K ﹤0.01% 2932
2023
Q1
$4K Hold
435
– – ﹤0.01% 4108
2022
Q4
$4.44K Hold
435
– – ﹤0.01% 4026
2022
Q3
$6K Hold
435
– – ﹤0.01% 3914
2022
Q2
$5K Hold
435
– – ﹤0.01% 3986
2022
Q1
$5K Hold
435
– – ﹤0.01% 3989
2021
Q4
$7K Buy
+435
New +$9.11K ﹤0.01% 3871

Other funds holding CTKB

PNC Financial Services Group's CTKB Position: Q3 2026 in Review

PNC Financial Services Group reduced its Cytek Biosciences (CTKB) stake by 29% in Q3 2026, selling an estimated $2.82K and leaving 1,427 shares worth $8.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4246.

PNC Financial Services Group first reported a position in CTKB in Q4 2021 and has held it in 20 quarters since. The position peaked at $82.5K in Q4 2025. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • PNC Financial Services Group held 1,427 shares of Cytek Biosciences worth $8.5K as of Q3 2026.
  • PNC Financial Services Group sold 595 Cytek Biosciences shares in Q3 2026, an estimated $2.82K.
  • Cytek Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4246 holding.
  • PNC Financial Services Group first reported a position in Cytek Biosciences in Q4 2021 and has held it in 20 quarters since.
  • PNC Financial Services Group's Cytek Biosciences position peaked at $82.5K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.